Ampio Pharmaceuticals, Inc. (AMPE)
- Previous Close
0.3210 - Open
0.3200 - Bid --
- Ask --
- Day's Range
0.3200 - 0.3201 - 52 Week Range
0.2200 - 8.2000 - Volume
8,413 - Avg. Volume
64,912 - Market Cap (intraday)
363,315 - Beta (5Y Monthly) 1.95
- PE Ratio (TTM)
-- - EPS (TTM)
-10.6600 - Earnings Date May 6, 2024 - May 10, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
ampiopharma.comRecent News: AMPE
Performance Overview: AMPE
Trailing total returns as of 4/29/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMPE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMPE
Valuation Measures
Market Cap
364.45k
Enterprise Value
-3.45M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.11
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
0.37
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-61.57%
Return on Equity (ttm)
-113.96%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-8.63M
Diluted EPS (ttm)
-10.6600
Balance Sheet and Cash Flow
Total Cash (mrq)
4.12M
Total Debt/Equity (mrq)
13.42%
Levered Free Cash Flow (ttm)
-5.37M
Research Analysis: AMPE
Company Insights: AMPE
AMPE does not have Company Insights